--- title: Streamline Safety Process with Safety Shield pre-reading tools description: "Enhance pharmacovigilance efficiency by 80% with AI-powered SafetyShield™ for pre-reading, prioritizing critical safety signals\nStreamline PV workflow and improve patient safety with SafetyShield™ - the intelligent assistant for pharmacovigilance specialists\nRevolutionize drug safety management with SafetyShield™ - the game-changing AI automation for pharmacovigilance" image: https://contents.arcascience.ai/hubfs/Email-3.png --- [![Fichier 7](https://contents.arcascience.ai/hs-fs/hubfs/Fichier%207.png?width=200&height=56&name=Fichier%207.png "Fichier 7")](https://contents.arcascience.ai/improve-clinical-trial-patient-recruitmen-with-key-opinion-leader-report?hs_preview=jnsbfdkc-96416875766&hsLang=en) Search ## Reduce Manual Workload by 80% in Pharmacovigilance: Focus on important Safety Signals with AI ### AS SafetyShield™ - Your Intelligent Assistant for ICSR Pre-reading. It helps you decide what to read. 100% 80% 37% Reduction of manual literature searching time Reduction of reading time More accurate results in article selection ![Hero_part](https://contents.arcascience.ai/hs-fs/hubfs/Hero_part.png?width=450&height=450&name=Hero_part.png "Hero_part") See the Future of PV - Download a Sample Report [Book now and receive a complimentary Safety IT diagnosis](https://contents.arcascience.ai/meetings/jdufour?hsLang=en) ![Hero_part-1](https://contents.arcascience.ai/hs-fs/hubfs/Hero_part-1.png?width=450&height=450&name=Hero_part-1.png "Hero_part-1") ## Information overload threatens the signal detection activities PV specialists are the backbone of patient safety, yet they face significant challenges: - **Information Overload:** They're constantly bombarded with research, reports, and ever-changing regulations. This creates an avalanche of data that's difficult to manage. - **Manual Review Bottleneck:** Manually sifting through this information is painfully slow, delaying the identification of critical safety signals. This delay can have a direct impact on patient safety. - **Incomplete Oversight vs. Efficiency:** Many workflow streamlining solutions prioritize speed, often sacrificing complete oversight. This creates a dangerous blind spot, potentially missing crucial safety information. # Discover exclusives insights ## Reduced to zero your searching time: ### Pre-selected articles eliminate the need for extensive manual searching of medical literature databases.  AI-powered Summarization: Get to know a unique ICSR-based pre-reading AI building concise summaries of relevant publications with extracts, highlighting key safety and efficacy insights. Your browser does not support the video tag. ## Process a high volume of information and prioritize the most important signals ### Quickly identify potentially safety-critical issues and maintain complete control over decision-making. Safety Shield provides in-depth insights into relevant articles through 3 progressive information levels: - Basic Details: Title, author, affiliation, and publication date. - Drug-Focused Summary: A concise overview highlighting key points related to your specific drug. - Extracts for Analysis: Excerpts from the document categorized by Drug, Patient, Safety, and Efficacy for a deeper understanding. See the Future of PV - Download a Sample Report ## Unify your ICSR pre-reading method ### Streamline your PV workflow with AI-powered document review SafetyShield can process both public literature and your private data to harmonize and aggregate all potential PV case sources, applying the same methodology throughout. # Before and after Safety Shield ### BEFORE ### 80% of time consuming  dedicated to manual reviews. This tedious process not only eats away at valuable research hours but also introduces the risk of human error. ### Safety signals missed Critical safety issues buried in a sea of data can go unnoticed, jeopardizing patient safety. ### Delayed responses Inefficient workflows can create a domino effect, ultimately leading to safety regulatory non-compliance ![Safetyshield overview-1](https://contents.arcascience.ai/hs-fs/hubfs/Safetyshield%20overview-1.png?width=450&height=686&name=Safetyshield%20overview-1.png "Safetyshield overview-1") ### AFTER ### Automated analysis  Frees Up Valuable Time for Specialists: A 70% Reduction in Tedious Tasks. By automating routine pharmacovigilance activities. ### Prioritized safety investigation Safety Shield allows PV specialists to take immediate action for each safety case. ### Faster decision-making While efficiency is often associated with productivity, in PV, it plays a crucial role in safeguarding patient well-being.  # Testimonials ![Ishana R.](https://contents.arcascience.ai/hs-fs/hubfs/Ishana%20R-1.png?width=100&height=100&name=Ishana%20R-1.png) Safety Shield has been a game-changer for our team. Its intelligent automation streamlines our workflows, allowing us to analyze vast amounts of data with greater speed and accuracy. **This empowers us to identify and prioritize critical safety signals faster**, ultimately leading to more proactive and informed decisions that mitigate risks. #### Ishana R. Intelligent Safety Automation ![Steven S.](https://contents.arcascience.ai/hs-fs/hubfs/Steven.png?width=100&height=100&name=Steven.png) *Safety Shield has been a game-changer for our pharmacovigilance team.  It's freed us up from tedious manual tasks and **allowed us to focus on what truly matters – analyzing safety data and making informed decisions**.  We've seen a dramatic **improvement in our efficiency and feel much more confident** in our ability to protect patient safety.* #### Steven S. Pharmacovigilance Specialist ![Sarah J.](https://contents.arcascience.ai/hs-fs/hubfs/Sarah.png?width=100&height=100&name=Sarah.png) *Implementing SafetyShield has revolutionized how we handle drug safety.  Before, our team was drowning in a sea of data.  Now, with the help of AI-powered automation, we can **identify potential safety signals much faster and prioritize the most critical issues**. This has significantly improved our ability to ensure patient safety throughout the drug development process.* #### Dr. Sarah J. Head of Pharmacovigilance [Discover our latest newsletters on Patients first with AI](https://contents.arcascience.ai/improve-clinical-trial-patient-recruitmen-with-key-opinion-leader-report-1-0?hsLang=en) [Book now and receive a complimentary Safety IT diagnosis](https://contents.arcascience.ai/meetings/jdufour?hsLang=en) # Newsletter Patients first in drug development with Artificial Intelligence [Discover our latest newsletters on Patients first with AI](https://contents.arcascience.ai/improve-clinical-trial-patient-recruitmen-with-key-opinion-leader-report-1-0?hsLang=en) ## Recommended by ![PFE_BIG.D-8e6e4bdc (1)](https://contents.arcascience.ai/hs-fs/hubfs/PFE_BIG.D-8e6e4bdc%20(1).png?width=70&height=29&name=PFE_BIG.D-8e6e4bdc%20(1).png) ![output-onlinepngtools (1)](https://contents.arcascience.ai/hs-fs/hubfs/output-onlinepngtools%20(1).png?width=79&height=27&name=output-onlinepngtools%20(1).png) ![logo_white_sanofi (4) (1)](https://contents.arcascience.ai/hs-fs/hubfs/logo_white_sanofi%20(4)%20(1).png?width=85&height=25&name=logo_white_sanofi%20(4)%20(1).png) ![gsk-logo-white (1)](https://contents.arcascience.ai/hs-fs/hubfs/gsk-logo-white%20(1).png?width=80&height=24&name=gsk-logo-white%20(1).png) ![icm-logo-blanc-horiz (1)](https://contents.arcascience.ai/hs-fs/hubfs/icm-logo-blanc-horiz%20(1).png?width=139&height=23&name=icm-logo-blanc-horiz%20(1).png) ![InsermSeul_rvb_blanc_0 (1) (1)](https://contents.arcascience.ai/hs-fs/hubfs/InsermSeul_rvb_blanc_0%20(1)%20(1).png?width=109&height=25&name=InsermSeul_rvb_blanc_0%20(1)%20(1).png) ![output-onlinepngtools (6) (1)](https://contents.arcascience.ai/hs-fs/hubfs/output-onlinepngtools%20(6)%20(1).png?width=140&height=23&name=output-onlinepngtools%20(6)%20(1).png) ![output-onlinepngtools (4) (1)](https://contents.arcascience.ai/hs-fs/hubfs/output-onlinepngtools%20(4)%20(1).png?width=80&height=35&name=output-onlinepngtools%20(4)%20(1).png) ![CAP.PA_BIG.D-679c041e (1)](https://contents.arcascience.ai/hs-fs/hubfs/CAP.PA_BIG.D-679c041e%20(1).png?width=90&height=20&name=CAP.PA_BIG.D-679c041e%20(1).png) [![Fichier 7](https://contents.arcascience.ai/hs-fs/hubfs/Fichier%207.png?width=200&height=56&name=Fichier%207.png "Fichier 7")](https://fr.arcascience.org/) *The Patient centric AI company* © 2026 All rights reserved | [Legal mentions](https://www.arcascience.ai/legal-mention) ![](https://px.ads.linkedin.com/collect/?pid=6097210&fmt=gif)